Skip to content

Clinical Observation on the Treatment of Chronic Neck, Shoulder, Low Back and Leg Pain by Regulating Tendons and Bonesetting Manipulation

Clinical Observation on the Treatment of Chronic Neck, Shoulder, Low Back and Leg Pain by Regulating Tendons and Bonesetting Manipulation

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400090977
Enrollment
Unknown
Registered
2024-10-17
Start date
2024-05-06
Completion date
Unknown
Last updated
2024-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic neck, shoulder, back and leg pain

Interventions

Control Group:Routine treatment, including: transcutaneous electrical nerve stimulation, intermediate frequency pulsed electrical therapy, ultrashort wave therapy. 1 time/d, 5d for 1 course of treatme
Treatment Group :On the basis of the control group +tendon-bone-setting manipulation, 1 week treatment 3 times, 5 consecutive weeks of treatment.

Sponsors

The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria for chronic neck pain, frozen shoulder, rotator cuff injury, nonspecific lower back pain, osteoarthritis of the knee, patellofemoral syndrome, and ankle sprain for chronic neck, shoulder, and low back pain; (2) Age 18 to 70 years old, disease duration = 3 months; (3) Clear consciousness and good communication skills, able to cooperate with the treatment. (4) Voluntarily participate in the study, willing to cooperate with the treatment and follow-up, and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Neck, shoulder, back and leg pain due to specific causes such as fractures, dislocations, tumors and infections; (2) Neck pain with spinal cord symptoms; (3) Localized skin breakdown, skin disease or skin sensory disorders; (4) Those with cognitive impairment and unable to cooperate with treatment; (5) Those with serious primary illnesses, mental illnesses, etc; (6) Pregnant or lactating women; (7) Combined cardiovascular and cerebrovascular system diseases, serious abnormalities of liver and kidney functions, abnormalities of coagulation function, serious abnormalities of electrocardiogram, etc; (8) Do not agree to sign the informed consent for this study.

Design outcomes

Primary

MeasureTime frame
VAS;surface EMG;muscle and bone ultrasound;isometric muscle power;

Secondary

MeasureTime frame
magnetic resonance imaging (MRI);SF-36;EQ-5D;

Countries

China

Contacts

Public Contactli dongjing

The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine

1425374970@qq.com+86 158 5696 1068

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026